The Valley Desk

NCT00075868 · Interventional trial

Octreotide in Preventing or Reducing Diarrhea in Patients Receiving Chemoradiotherapy for Anal or Rectal Cancer

Overall registry status Completed

Phase 3

Conditions Anal Cancer, Colorectal Cancer, Drug/Agent Toxicity by Tissue/Organ, Radiation Enteritis

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov